NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER
Clinical trials for NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER explained in plain language.
Never miss a new study
Get alerted when new NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER trials appear
Sign up with your email to follow new studies for NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Milder chemo before stem cell transplant may help treat non-cancer blood disorders with fewer side effects
Disease control Recruiting nowThis study tests a less intense chemotherapy combination (treosulfan, fludarabine, and thiotepa) given before a donor stem cell transplant for people with non-cancerous blood or immune system disorders. The goal is to see if this gentler regimen can still allow the donor cells to…
Matched conditions: NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
Can we predict blood cancer in ovarian cancer survivors?
Knowledge-focused Recruiting nowThis study follows 2,000 people who have had ovarian or other solid cancers to learn why some later develop blood cancers like leukemia. Researchers will look at genetic changes in blood cells and treatment history to identify risk factors. No new treatments are being tested—the …
Matched conditions: NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 24, 2026 02:36 UTC